atHeart Medical
atHeart Medical Aims to Evolve Septal Closure with the reSept™ ASD Occluder: Commences Operations
Company has commenced operations and is initiating its U.S. Investigational Device Exemption (IDE) trial.
About us
Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.
Need to know more?